The preventative role of heparin in antiphospholipid antibody-induced fetal loss
Future Rheumatology · 2006
DOI: 10.2217/17460816.1.1.23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Future Rheumatology, 2006. Verfasst von Ronald A Asherson. Die Arbeit nennt 19 Literaturangaben.
Abstract (Originalsprache)
Evaluation of: Girardi G, Redecha P, Salmon J: Heparin prevents antiphospholipid-antibody induced fetal loss by inhibiting complement activation. Nature Med. 10, 1222–1226 (2004). Recurrent fetal loss is one of the most important criteria for the diagnosis of antiphospholipid syndrome (APS), along with venous and arterial thromboses, which are usually recurrent. Since the description of the syndrome in 1983, it has been assumed that the mechanism for fetal loss was due to thrombosis. However, this has not been borne out by histopathological studies of many placentae studied from patients with APS. Girardi and colleagues demonstrated previously that complement activation is an essential factor in initiating pregnancy loss, leading to complement C3 activation and deposition with an influx of inflammatory cells into the placenta. This paper demonstrates for the first time that heparin (unfractionated or low molecular weight) prevents complement activation and inhibits the generation of complement split produ...
Zitieren
APA
Asherson, R. A. (2006). The preventative role of heparin in antiphospholipid antibody-induced fetal loss. Future Rheumatology. https://doi.org/10.2217/17460816.1.1.23
Vancouver
Asherson RA. The preventative role of heparin in antiphospholipid antibody-induced fetal loss. Future Rheumatology. 2006. doi:10.2217/17460816.1.1.23
BibTeX
@article{Asherson2006,
author = {Asherson, Ronald A},
title = {The preventative role of heparin in antiphospholipid antibody-induced fetal loss},
journal = {Future Rheumatology},
year = {2006},
doi = {10.2217/17460816.1.1.23}
}
EUVIMED